Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank M Balis

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|January 17, 2002
Evolution of anticancer drug discovery and the role of cell-based screeningFrank M Balis
Clinical Chemistry|December 2, 2010
CommentaryElizabeth Fox, Frank M Balis
Cancer Chemotherapy and Pharmacology|October 13, 2016
15-0600-Dr. Fox's response to letter to the editorElizabeth Fox, Frank M Balis
Nucleic Acids Research|April 20, 2004
Use of pteridine nucleoside analogs as hybridization probesMary E Hawkins, Frank M Balis
Clinical Biochemistry|December 20, 2021
Age-dependent reference intervals in children for the disialoganglioside, G<sub>D2</sub>, a circulating tumor biomarker for the childhood cancer, neuroblastomaChristine M Busch, Frank M Balis
Journal of the National Cancer Institute|August 4, 2009
The legacy of cancer therapy in childrenElizabeth Fox, Deborah Citrin, Frank M Balis
The Oncologist|October 29, 2002
Clinical trial design for target-based therapyElizabeth Fox, Gregory A Curt, Frank M Balis
The Oncologist|August 4, 2009
Sorafenib and sunitinibAeRang Kim, Frank M Balis, Brigitte C Widemann
The Oncologist|August 18, 2009
TrabectedinMeredith K Chuk, Frank M Balis, Elizabeth Fox
Journal of Neuro-Oncology|April 5, 2003
Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primatesMahendra Patel, Cynthia McCully, Karen Godwin, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|January 17, 2002
Evolution of anticancer drug discovery and the role of cell-based screeningFrank M Balis
Clinical Chemistry|December 2, 2010
CommentaryElizabeth Fox, Frank M Balis
Cancer Chemotherapy and Pharmacology|October 13, 2016
15-0600-Dr. Fox's response to letter to the editorElizabeth Fox, Frank M Balis
Nucleic Acids Research|April 20, 2004
Use of pteridine nucleoside analogs as hybridization probesMary E Hawkins, Frank M Balis
Clinical Biochemistry|December 20, 2021
Age-dependent reference intervals in children for the disialoganglioside, G<sub>D2</sub>, a circulating tumor biomarker for the childhood cancer, neuroblastomaChristine M Busch, Frank M Balis
Journal of the National Cancer Institute|August 4, 2009
The legacy of cancer therapy in childrenElizabeth Fox, Deborah Citrin, Frank M Balis
The Oncologist|October 29, 2002
Clinical trial design for target-based therapyElizabeth Fox, Gregory A Curt, Frank M Balis
The Oncologist|August 4, 2009
Sorafenib and sunitinibAeRang Kim, Frank M Balis, Brigitte C Widemann
The Oncologist|August 18, 2009
TrabectedinMeredith K Chuk, Frank M Balis, Elizabeth Fox
Journal of Neuro-Oncology|April 5, 2003
Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primatesMahendra Patel, Cynthia McCully, Karen Godwin, et al.
Pageof 10